Thrombolex Receives FDA Clearance for Bashir Endovascular Catheters

Updated: May 21, 2019

May 13, 2019—Thrombolex, Inc. announced FDA 510(k) clearance for the Bashir endovascular catheter (BEC) and the Bashir N-X endovascular catheter (BEC N-X). The BEC and BEC N-X are currently only available in the United States. Plans for distribution outside the United States are forthcoming. To read more click the link below.

https://evtoday.com/2019/05/16/thrombolex-receives-fda-clearance-for-bashir-endovascular-catheters?utm_source=iContact&utm_medium=email&utm_campaign=evt-enews&utm_content=





108 views